Supercritical Fluid Extraction of Michellamine B
Award amount
$637,570Program and phase
SBIR · Phase IIAward year
1996Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Aphios Corporation
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HDE2J1H521A7
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Botanical Drug for Chemotherapy Induced Nausea and Vomiting
- Development of a Novel Alzheimer's Disease Therapeutic
- Combination Therapeutic for Chronic Opioid Use Disorder Relapse
- Double-Encapsulated mRNA Vaccine for COVID-19
- CFI Pathogen Inactivation of Human Plasma Units
Research funding history
44 SBIR/STTR records share this UEI (1994–2025). Reported award amounts total $17,170,079. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Defense